These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
568 related items for PubMed ID: 1662941
1. [Therapeutic indications of low molecular weight heparins]. Samama MM, Michaut-Paterno F. Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941 [Abstract] [Full Text] [Related]
8. Reviparin sodium clivarine: a review of its therapeutic use. Gore M, Kelkar P, Rege N, Ross C. J Indian Med Assoc; 2004 Oct; 102(10):589-90, 592. PubMed ID: 15887830 [Abstract] [Full Text] [Related]
12. M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes. Kishimoto TK, Qi YW, Long A, Capila I, Sasisekharan R, Guerrero L, Fier I, Roach J, Venkataraman G. Thromb Haemost; 2009 Nov 23; 102(5):900-6. PubMed ID: 19888526 [Abstract] [Full Text] [Related]
13. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS. Clin Ther; 2007 Nov 23; 29(11):2395-405. PubMed ID: 18158080 [Abstract] [Full Text] [Related]
14. Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics. Agnelli G, Sonaglia F. Haematologica; 2002 Jul 23; 87(7):757-70. PubMed ID: 12091128 [Abstract] [Full Text] [Related]
18. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Bratt G, Törnebohm E, Granqvist S, Aberg W, Lockner D. Thromb Haemost; 1985 Dec 17; 54(4):813-7. PubMed ID: 3911482 [Abstract] [Full Text] [Related]
19. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Br J Surg; 2001 Jul 17; 88(7):913-30. PubMed ID: 11442521 [Abstract] [Full Text] [Related]
20. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio]. Barata JD, Oliveira C, Bruges M, Gusmão L, Santana A, Ponce P, Simões J, Freire I, Crespo F, da Silva AN. Acta Med Port; 1992 Feb 17; 5(2):65-70. PubMed ID: 1317657 [Abstract] [Full Text] [Related] Page: [Next] [New Search]